Ikarian Capital, LLC
Ikarian Capital, LLC reported 172 positions worth $504.1M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: MRNA (7.7%). Biggest move: add BMY ($59.3M).
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | MRNAPut | $77.0M notional | 7.75% | 400,000 | — | — | — | |
| ▸ 2 | BMYPut | $61.9M notional | 6.23% | 992,500 | — | — | — | |
| ▸ 3 | KOD | $50.5M | 5.08% | 533,113 | — | — | +6.3% | |
| ▸ 4 | XBIPut | $47.3M notional | 4.76% | 300,000 | — | — | — | |
| ▸ 5 | PRAXCall | $29.1M notional | 2.92% | 99,800 | — | — | — | |
| ▸ 6 | ABVX | $28.4M | 2.86% | 285,909 | — | — | — | |
| ▸ 7 | IRONPut | $25.5M notional | 2.56% | 389,100 | — | — | — | |
| ▸ 8 | PCVX | $22.8M | 2.29% | 400,465 | — | — | +8.3% | |
| ▸ 9 | RCUS | $19.0M | 1.91% | 734,559 | — | — | -32.5% | |
| ▸ 10 | INCYPut | $18.2M notional | 1.83% | 150,000 | — | — | — |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Ikarian Capital, LLC hold as of Q3 2026?
Ikarian Capital, LLC reported 172 positions worth $504.1M in its Q3 2026 13F filing. Largest positions: MRNA (7.7%), BMY (6.2%), KOD (5.1%), XBI (4.8%) and PRAX (2.9%).
What did Ikarian Capital, LLC buy in Q3 2026?
New positions: INCY, ACAD, PCVX, SMMT and RAPP (49 in all). Added to: BMY, IRON, PRAX, AMLX and IRON (28 in all).
What did Ikarian Capital, LLC sell in Q3 2026?
Reduced: KOD, ABVX, PRAX, ANIP and BHVN (37 in all). Sold out entirely: ABVX, IONS, IONS, NEWAMSTERDAM PHARMA COMPANY and DAMORA THERAPEUTICS INC (33 in all).
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.